Product Description
| Brand |
Medtronic |
| Stent Diameter (mm) |
3.50 |
| Stent Length (mm) |
15 & 22 |
| CAT No |
RONYX35015W & RONYX25022W |
| Catheter Length |
300 cm |
Resolute Onyx is a drug-eluting stent (DES) that's different by design, optimised for complex PCI, and proven safe and effective in real-world, high bleeding risk patients on 1-month dual antiplatelet therapy (DAPT).A Resolute Onyx drug-eluting stent (DES) offers flexibility, conformability, a 2.0-5.0 mm size matrix, and is indicated for high bleeding risk patients and labeled for one-month DAPT.
Advanced Drug-Eluting Technology for Coronary InterventionsThe Resolute Onyx DES leverages proprietary BioLinx polymer to enable everolimus drug release, promoting healing and reducing restenosis risk. Its thin strut design and enhanced flexibility aid navigation through complex vascular anatomy, making it suitable for a range of PCI procedures. This innovation supports optimal patient outcomes by combining therapeutic efficacy with outstanding deliverability.
Superior Visibility and Accurate DeploymentThanks to its platinum-iridium core, the Resolute Onyx DES delivers excellent radiopacity, allowing clinicians to visualize stent placement precisely under fluoroscopy. The stent's high deployment accuracy, balloon-expandable nature, and broad size matrix simplify procedural workflow, facilitating tailored treatment in coronary artery disease cases.
FAQ's of Medtronic Resolute Onyx DES Drug-eluting Stent (SD 3.50):
Q: How does the Medtronic Resolute Onyx DES deliver its therapeutic benefits?
A: This stent utilizes the BioLinx polymer coating to enable controlled release of everolimus, a drug that reduces the risk of restenosis by minimizing neointimal hyperplasia within the stented coronary artery.
Q: What is the recommended process for deploying the Resolute Onyx DES during PCI?
A: The stent is delivered via a rapid-exchange system compatible with 5F guide catheters. Recommended nominal inflation pressure is 9-12 atm, with a maximum of 16 atm, ensuring precise expansion for optimal vessel support.
Q: When and where should the Medtronic Resolute Onyx DES be used?
A: This device is intended for use during percutaneous coronary intervention procedures in catheterization labs, specifically in patients with coronary artery disease requiring vessel stenting for arteries ranging from 3.0 to 3.75 mm in diameter.
Q: What makes the Resolute Onyx DES visible under fluoroscopy?
A: Its platinum-iridium core provides excellent radiopacity, enabling clinicians to clearly see the stent during implantation and verify accurate placement inside the vessel.
Q: How should the Resolute Onyx DES be stored before use?
A: The stent should be stored in a cool, dry environment, avoiding excessive heat, and remains sterile in its single-use packaging until the time of the procedure.
Q: What are the sizing and compatibility features of this stent?
A: The Resolute Onyx DES is available in several lengths (from 8 mm up to 38 mm) with a diameter of 3.50 mm, ensuring compatibility with a variety of vessel anatomies. It is designed for use with 5F guide catheters.
Q: What are the main benefits of using the Resolute Onyx DES in interventional cardiology?
A: Key benefits include high biocompatibility, enhanced deliverability, thin strut design for flexibility, excellent radiopacity for precise placement, and long-term efficacy in reducing restenosis rates.